The IL2 pathway in clinical immunosuppression.
Standard
The IL2 pathway in clinical immunosuppression. / Nashan, Björn.
in: TRANSPL P, Jahrgang 33, Nr. 7-8, 7-8, 2001, S. 3072-3074.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Nashan, B 2001, 'The IL2 pathway in clinical immunosuppression.', TRANSPL P, Jg. 33, Nr. 7-8, 7-8, S. 3072-3074. <http://www.ncbi.nlm.nih.gov/pubmed/11750321?dopt=Citation>
APA
Nashan, B. (2001). The IL2 pathway in clinical immunosuppression. TRANSPL P, 33(7-8), 3072-3074. [7-8]. http://www.ncbi.nlm.nih.gov/pubmed/11750321?dopt=Citation
Vancouver
Nashan B. The IL2 pathway in clinical immunosuppression. TRANSPL P. 2001;33(7-8):3072-3074. 7-8.
Bibtex
@article{e3ed5a3a1e3e433eb181cda2783997ff,
title = "The IL2 pathway in clinical immunosuppression.",
author = "Bj{\"o}rn Nashan",
year = "2001",
language = "Deutsch",
volume = "33",
pages = "3072--3074",
journal = "TRANSPL P",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "7-8",
}
RIS
TY - JOUR
T1 - The IL2 pathway in clinical immunosuppression.
AU - Nashan, Björn
PY - 2001
Y1 - 2001
M3 - SCORING: Zeitschriftenaufsatz
VL - 33
SP - 3072
EP - 3074
JO - TRANSPL P
JF - TRANSPL P
SN - 0041-1345
IS - 7-8
M1 - 7-8
ER -
